0
0

Department of Veterans Affairs Awarded a Contract to EXELAN PHARMACEUTICALS INC for $3,250,000.00

Signed on

1/28/2026, 12:00 AM

EXELAN PHARMACEUTICALS INC Government Contract #36C26226N0346

EXELAN PHARMACEUTICALS INC was awarded a contract with the United States Government for $3,250,000.00. The contract was awarded by the agency office 262-NETWORK CONTRACT OFFICE 22 (36C262), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is Exelan Pharmaceuticals Inc, a pharmaceutical company based in Boca Raton, Florida. The contract is for supplying Lenalidomide to the VA San Diego HealthCare System, funded by the Department of Veterans Affairs, with a total value of $3,250,000. The contract was awarded through a BPA call with full and open competition. The notable transaction is the award amount of $3,250,000 to Exelan Pharmaceuticals Inc for the pharmaceutical supply.

Contract Details

Contract ID36C26226N0346
Contract TypeA
Total Obligation$3,250,000.00
Exercised Options$3,250,000.00
Base Amount + Options$3,250,000.00
Date Signed2026-01-28
Contract DescriptionLENALIDOMIDE VA SAN DIEGO DO
Start Date2026-01-28
End Date2027-01-14

Agency Details

Awarding AgencyDepartment of Veterans Affairs
Awarding Sub AgencyDepartment of Veterans Affairs
Awarding Office262-NETWORK CONTRACT OFFICE 22 (36C262)
Funding AgencyDepartment of Veterans Affairs
Funding Sub AgencyDepartment of Veterans Affairs
Funding Office664-SAN DIEGO HEALTHCARE SYS(00664)

Recipient Details

RecipientEXELAN PHARMACEUTICALS INC
Recipient Location370 W CAMINO GARDENS BLVD STE 204 BOCA RATON FLORIDA, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Not Designated a Small Business, Special Designations

Comments

Award Transactions

Transaction #0$3,250,000.00January 28, 2026

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $3,250,000.00 to EXELAN PHARMACEUTICALS INC. The payment included a Subsidy Cost of $0.00.